Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Alois Alzheimer Stories

2008-07-30 18:00:22

A NEW drug could prove at least twice as effective in treating Alzheimer's disease as current medicines, according to new research. The drug, rember, slows progression of the disease by asmuch as 81%, a British-led study published last night found. People taking it for 50 weeks had a slower decline in blood flow to the parts of the brain that are important for memory than those taking a dummy pill. Rember is the first drugto act on the tau tangles that develop in the brains of people...

2008-07-30 18:00:17

By Jeremy Manier CHICAGO - A new treatment for Alzheimer's disease significantly slowed elderly patients' mental decline and may have revealed a new way of attacking the illness, according to a study presented Tuesday at a Chicago medical conference. In a study involving 321 Alzheimer's patients in Britain and Singapore, the treatment was found to reduce the rate of mental loss by 81 percent compared with a group that received a placebo, according to a standard test that measures...

2008-07-30 12:00:21

* Alzheimer's was first described in 1906 by the German neurologist Alois Alzheimer * According to the Alzheimer's Society the disease affects around 417,000 people in the UK * Sufferers from the disease have been shown to have a shortage of the chemical acetylcholine in their brains * In the course of the disease, 'plaques' and 'tangles' develop in the brain, leading to the death of brain cells * People in the early stages may experience lapses of memory and have problems finding the...

2008-07-30 12:00:21

By JANE KIRBY EXPERTS today hailed a new drug which could prove at least twice as effective in treating Alzheimer's disease as current medicines as a "major development". The drug, rember, slows progression of the disease by as much as 81%, a British-led study found. And it could benefit thousands of sufferers. People taking it for 50 weeks had a slower decline in blood flow to the parts of the brain that are important for memory than those taking a dummy pill. Rember is the first...

2008-07-30 12:00:07

By JANE KIRBY A new drug could prove at least twice as effective in treating Alzheimer's disease as current medicines, new research has shown. The drug, rember, slows progression of the disease by as much as 81%, a British-led study has found. People taking it for 50 weeks had a slower decline in blood flow to the parts of the brain that are important for memory than those taking a dummy pill. Rember is the first drug to act on the tau tangles that develop in the brains of people with...

2008-07-30 06:00:16

By Lyndsay Moss A NEW drug capable of halting Alzheimer's disease in its tracks was hailed yesterday as a "hugely exciting" development in the battle against the devastating condition. The drug, developed and tested on patients in Scotland, slows down the progression of Alzheimer's by as much as 81 per cent. Those given the drug in the ongoing trials, which have been running for 19 months, experienced no significant decline in their mental function. It is thought that the drug -...

2008-07-30 03:00:15

Researchers at Scotland's University of Aberdeen say a new drug they've developed holds great promise in slowing the progression of Alzheimer's disease. The test patients who took the medication had an 81 percent reduction in cognitive decline in one year, the researchers' Phase 2 clinical trial found. The university's Claude Wischik, working with TauRx Therapeutics of Singapore, developed the novel treatment based on a new approach that targets the tangles -- aggregates of abnormal...

2008-07-30 00:00:02

By Jeremy Laurance Health Editor The first of a new class of treatments for Alzheimer's disease has been shown to be more than twice as effective as existing drugs in slowing progression of the condition, scientists said yesterday. The drug, Rember, is the latest of a group of new treatments for the degenerative disease announced in the past two weeks but one with the greatest potential, experts said. Rember is the first drug to act on the nerve tangles discovered by Alois Alzheimer a...

2008-07-29 15:01:15

CHICAGO _ A new treatment for Alzheimer's disease significantly slowed elderly patients' mental decline and may have revealed a new way of attacking the illness, according to a study presented Tuesday at a Chicago medical conference. In a study involving 321 Alzheimer's patients in Britain and Singapore, the treatment was found to reduce the rate of mental loss by 81 percent compared with a group that received a placebo, according to a standard test that measures cognitive performance and...

2008-06-27 00:02:36

This is your brain on Facebook. Researchers at the Stanford University School of Medicine used concepts borrowed from the popular social networking site to analyze the brains of people with Alzheimer's disease. They found that patients' brains were less well-connected than the brains of people without the disorder. The test, which relies on common brain-imaging techniques, may be the first step toward a new diagnostic tool to differentiate early-stage Alzheimer's disease from other...